Q4 2025 Holdings
Filed 2026-02-12 | 19 holdings | $743.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $264.6M | 6,371,669 | 35.6% |
| Nuvation Bio Inc.(NUVB) | COM | 67080N101 | $232.6M | 25,954,439 | 31.3% |
| Upstream Bio Inc.(UPB) | COM | 91678A107 | $85.3M | 3,143,078 | 11.5% |
| Aardvark Therapeutics Inc(AARD) | COM | 002942100 | $51.4M | 3,917,299 | 6.9% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $21.3M | 692,050 | 2.9% |
| Newamsterdam Pharma Co NV(NAMS) | COM | N62509109 | $20.8M | 592,057 | 2.8% |
| Revolution Medicines Inc(nsm)(RVMD) | COM | 76155X100 | $15.9M | 200,000 | 2.1% |
| Arcus Biosciences, Inc(RCUS) | COM | 03969F109 | $12.9M | 541,559 | 1.7% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $12.2M | 4,041,736 | 1.6% |
| Equillium Inc.(EQ) | COM | 29446K106 | $6.9M | 4,447,308 | 0.9% |
| BeyondSpring Inc.(BYSI) | SHS | G10830100 | $6.2M | 3,800,702 | 0.8% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $4.3M | 92,700 | 0.6% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $4.3M | 17,300 | 0.6% |
| Aura Biosciences, Inc.(AURA) | COM | 05153U107 | $2.0M | 360,483 | 0.3% |
| Zentalis Pharmaceuticals Inc.(ZNTL) | COM | 98943L107 | $1.8M | 1,323,327 | 0.2% |
| Pyxis Oncology, Inc (formerly Apexigen)(PYXS) | COM | 747324101 | $375.8K | 326,810 | 0.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $332.3K | 44,311 | 0.0% |
| Nuvation Bio Inc.(NUVB/WS) | WARRANTS | 67080N119 | $213.2K | 646,057 | 0.0% |
| Rezolute Inc(RZLT) | COM | 76200L309 | $141.4K | 59,900 | 0.0% |